AGIF
AGIF Brand names, AGIF Analogs
AGIF Brand Names Mixture
- No information avaliable
AGIF Chemical_Formula
C854H1411N253O235S2
AGIF RX_link
http://www.rxlist.com/cgi/generic3/oprelvek.htm
AGIF fda sheet
AGIF msds (material safety sheet)
AGIF Synthesis Reference
No information avaliable
AGIF Molecular Weight
19047.2
AGIF Melting Point
No information avaliable
AGIF H2O Solubility
No information avaliable
AGIF State
Liquid
AGIF LogP
-0.070
AGIF Dosage Forms
Powder for solution; Solution (subcutaneous injection)
AGIF Indication
Increases reduced platelet levels due to chemotherapy
AGIF Pharmacology
Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis
AGIF Absorption
No information avaliable
AGIF side effects and Toxicity
No information avaliable
AGIF Patient Information
No information avaliable
AGIF Organisms Affected
Humans and other mammals
